Sullivan A. Ayuso
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sullivan A. Ayuso has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
B. Todd Heniford
6 shared publicationsVedra A. Augenstein
6 shared publicationsVictoria L. Walker
Department of Surgery, Baptist Memorial Health Hospital, Memphis, TN, USA
6 shared publications- B. Todd Heniford
Division of Gastrointestinal and General Surgery, Department of Surgery, Evanston Hospital, Endeavor Health, Grainger Center for Simulation and Innovation, Evanston, USA
5 shared publications Michael B. Ujiki
Division of Gastrointestinal and General Surgery, Department of Surgery, Endeavor Health, Evanston, USA
5 shared publicationsKent W. Kercher
4 shared publications
Latest Publications
- 14 February 2026
- Published by Elsevier in The American Journal of Surgery
- Vol. 255, 116868
The final Year(s): Reflections and revelations on surgical fellowship
- 14 February 2026
- Published by Elsevier in The American Journal of Surgery
- Vol. 255, 116868
The final Year(s): Reflections and revelations on surgical fellowship
- Open Access
- 12 January 2026
- Published by Wolters Kluwer Health in Annals of Surgery Open
- Vol. 7 (1) , e648
Beyond the Operating Room: The Lasting Impact of Preoptimization in Abdominal Wall Reconstruction
- 12 January 2026
- Published by Wolters Kluwer Health in Annals of Surgery Open
- Vol. 7 (1) , e648
Open AccessBeyond the Operating Room: The Lasting Impact of Preoptimization in Abdominal Wall Reconstruction
- 17 December 2025
- Published by Springer Nature in Hernia
- Vol. 30 (1) , 41
Does (patient) size matter? the impact of body mass index on outcomes for patients undergoing minimally invasive transversus abdominis release
Background Obesity increases the rate of postoperative wound complications for patients undergoing open abdominal wall reconstruction (AWR) and predisposes patients to hernia recurrence. While minimally invasive surgery (MIS) techniques minimize wound morbidity in obese patients, the exact degree to which this occurs remains unknown. Methods A prospectively maintained single-institution hernia database was queried for patients undergoing robotic-assisted (rTAR) from 2018 to 2024. Basic demographics, operative characteristics and postoperative outcomes were reviewed. A univariate analysis was performed to compare outcomes for patients with a BMI < 35 kg/m2 (low BMI) to those with BMI ≥ 35 kg/m2 (high BMI). The primary outcomes were 30-day surgical site infection (SSI) and hernia recurrence. Results There were 128 patients: 72 with low BMI and 56 with high BMI. Mean BMI for each group was 28.2±3.6 and 41.5±4.6 kg/m2, respectively (p < 0.01). There were more recurrent hernias (8.3% vs. 25.0%, p = 0.01) and larger hernia defects (median(Q1-3)) (101(35–192) vs. 150(98–240) cm2, p = 0.01) in the high BMI group. Most patients underwent bilateral TAR (69.4% vs. 73.2%, p = 0.70). There was no difference in SSI rate or (1.4% vs. 0.0%, p = 0.78) or hernia recurrence at 6 months (1.8% vs. 0.0%, p = 0.65). Quality of life outcomes were similar at 3 weeks and 6 months (each p > 0.05). Conclusion Despite having more complex hernias, the high and low BMI groups had comparable rates of 30-day SSI and short-term hernia recurrence. rTAR appears to be a safe and effective operation for patients with a BMI ≥ 35 kg/m2.
- 17 December 2025
- Published by Springer Nature in Hernia
- Vol. 30 (1) , 41
Does (patient) size matter? the impact of body mass index on outcomes for patients undergoing minimally invasive transversus abdominis release
Background Obesity increases the rate of postoperative wound complications for patients undergoing open abdominal wall reconstruction (AWR) and predisposes patients to hernia recurrence. While minimally invasive surgery (MIS) techniques minimize wound morbidity in obese patients, the exact degree to which this occurs remains unknown. Methods A prospectively maintained single-institution hernia database was queried for patients undergoing robotic-assisted (rTAR) from 2018 to 2024. Basic demographics, operative characteristics and postoperative outcomes were reviewed. A univariate analysis was performed to compare outcomes for patients with a BMI < 35 kg/m2 (low BMI) to those with BMI ≥ 35 kg/m2 (high BMI). The primary outcomes were 30-day surgical site infection (SSI) and hernia recurrence. Results There were 128 patients: 72 with low BMI and 56 with high BMI. Mean BMI for each group was 28.2±3.6 and 41.5±4.6 kg/m2, respectively (p < 0.01). There were more recurrent hernias (8.3% vs. 25.0%, p = 0.01) and larger hernia defects (median(Q1-3)) (101(35–192) vs. 150(98–240) cm2, p = 0.01) in the high BMI group. Most patients underwent bilateral TAR (69.4% vs. 73.2%, p = 0.70). There was no difference in SSI rate or (1.4% vs. 0.0%, p = 0.78) or hernia recurrence at 6 months (1.8% vs. 0.0%, p = 0.65). Quality of life outcomes were similar at 3 weeks and 6 months (each p > 0.05). Conclusion Despite having more complex hernias, the high and low BMI groups had comparable rates of 30-day SSI and short-term hernia recurrence. rTAR appears to be a safe and effective operation for patients with a BMI ≥ 35 kg/m2.
- Open Access
- 24 October 2025
- Published by Frontiers Media SA in Journal of Abdominal Wall Surgery
- Vol. 4, 15383
The Endoscopic Optimization for Obesity in Patients Undergoing Abdominal Wall Reconstruction
Introduction Obesity significantly increases the risk of complications following abdominal wall reconstruction (AWR), including surgical site infections (SSIs), wound dehiscence, and hernia recurrence rates of up to 35-40% (1-3). A BMI threshold of BMI ≥35 kg/m² has typically been identified as a threshold at which these risks rise substantially; however, prior data has shown that there is an increase starting at lower BMIs (4,5). With global obesity rates continuing to rise, hernia surgeons are increasingly tasked with managing high-risk patients whose comorbidities and functional limitations require careful optimization prior to surgery when possible (6). AWR is a benign procedure performed to restore function and improve quality of life rather. This distinction underscores the importance of maximizing perioperative outcomes, as the central goal is to achieve durable repair and enhance functionality. Despite this, there is currently no standardized, stepwise approach to prehabilitation that incorporates endoscopic bariatric therapies. This gap in clinical practice highlights an opportunity to integrate endoscopic weight-loss strategies, specifically endoscopic sleeve gastroplasty (ESG), into the preoperative pathway for patients undergoing AWR. This manuscript explores the rationale, benefits, limitations, and practical considerations of ESG as a potential prehabilitation strategy to improve outcomes in this high-risk population. Rationale for Weight Loss Prior to Abdominal Wall Reconstruction Weight loss prior to AWR improves both technical and clinical outcomes (7). Reducing visceral and subcutaneous adiposity can facilitate fascial approximation, reduce tension at the repair site, and lower the risk of postoperative complications (8). Enhancing a patient's functional capacity before surgery can also contribute to optimal outcomes by improving cardiopulmonary function, glycemic control, and overall patient resilience, factors that collectively reduce surgical risk and improve the overall health of the patient (5,9). In our practices at University of Texas Health Austin and Endeavor Health, implementation of a ketogenic diet supplemented by daily aerobic exercise has been effective in optimizing patients for surgery and resulted in sustained improvements in health following surgery (10). While we do not have a specific cut point for body mass index (BMI) prior to open AWR, in general, we encourage weight loss in all overweight and obese patients as each unit of BMI is associated with a significant reduction in wound complications (3). In patients with large hernias, weight loss has the important impact of facilitating fascial closure by reducing hernia and intra-abdominal volume, and it also reduces tension on the closed wound. Previous studies demonstrate that lack of fascial closure increases recurrence rates by 7-fold and that increasing obesity directly correlates with elevated intra-abdominal pressure (11,12). Traditionally, these lifestyle modifications (e.g. ketogenic diet and daily aerobic exercise) have been the cornerstone of perioperative weight management, whereas surgical or endoscopic weight loss interventions were typically reserved for patients with more severe obesity or those without urgent indications for hernia repair. The purpose of this opinion piece is to advocate for the inclusion of ESG as a complementary strategy within the existing perioperative optimization paradigm. In particular, this may be a valuable emerging technology to achieve a longer-term effect in comparison to lifestyle modifications alone. Primary Endobariatric Therapies and Clinical Benefits Two principal endobariatric options for weight loss include intragastric balloon (IGB) therapy and endoscopic sleeve gastroplasty (ESG). IGB involves the endoscopic placement of a saline-filled or air-filled balloon in the stomach, which induces early satiety and reduces caloric intake. By far, the most commonly used ballon in the United States, the OrberaTM (Boston Scientific, El Coyol, Costa Rica) (13). IGB is Food and Drug Administration (FDA) approved for a maximum duration of six months. During this timeframe, it can induce an excess weight loss of 30-40% (14). However, this weight loss is typically not durable, and weight often recurs once the balloon is removed. Given these limitations, ESG is the preferred endoscopic intervention for patients requiring more sustained weight loss and metabolic improvement. That said, for carefully selected patients who required rapid, short term weight reduction without permanent anatomical changes, IGB still remains a viable option. Although longer-term follow-up is needed, ESG may be considered as an endobariatric approach in the AWR setting. ESG involves transoral placement of full thickness sutures to reduce the stomach's size by 70-80%, mimicking the restrictive anatomy of a surgical sleeve gastrectomy that limits food intake and induces changes in gastrointestinal hormones involved in satiety without the need for resection (15). Importantly, this technique avoids entering the peritoneal cavity, which is particularly advantageous in patients with prior abdominal surgeries or mesh implantation. ESG produces most of the weight loss within six months, which is beneficial for a patient who is being optimized for a hernia repair. In the multi-center ESG Randomized Interventional Trial (MERIT-Trial), investigators enrolled 209 participants with class 1 or class 2 obesity (BMI 30-40 kg/m2) to assess the effects of ESG combined with lifestyle modifications (15). After 52 weeks, the primary endpoint of 25% excess weight loss (EWL) was met in 77% of patients in the ESG group compared to only 12% in the control group (lifestyle modifications). Put differently, the mean percentage of total body weight loss at 52 weeks was 13.6% for the ESG group and 0.8% for the control group. Impressively, 68% of patients undergoing ESG maintained their weight loss at two...
- 24 October 2025
- Published by Frontiers Media SA in Journal of Abdominal Wall Surgery
- Vol. 4, 15383
Open AccessThe Endoscopic Optimization for Obesity in Patients Undergoing Abdominal Wall Reconstruction
Introduction Obesity significantly increases the risk of complications following abdominal wall reconstruction (AWR), including surgical site infections (SSIs), wound dehiscence, and hernia recurrence rates of up to 35-40% (1-3). A BMI threshold of BMI ≥35 kg/m² has typically been identified as a threshold at which these risks rise substantially; however, prior data has shown that there is an increase starting at lower BMIs (4,5). With global obesity rates continuing to rise, hernia surgeons are increasingly tasked with managing high-risk patients whose comorbidities and functional limitations require careful optimization prior to surgery when possible (6). AWR is a benign procedure performed to restore function and improve quality of life rather. This distinction underscores the importance of maximizing perioperative outcomes, as the central goal is to achieve durable repair and enhance functionality. Despite this, there is currently no standardized, stepwise approach to prehabilitation that incorporates endoscopic bariatric therapies. This gap in clinical practice highlights an opportunity to integrate endoscopic weight-loss strategies, specifically endoscopic sleeve gastroplasty (ESG), into the preoperative pathway for patients undergoing AWR. This manuscript explores the rationale, benefits, limitations, and practical considerations of ESG as a potential prehabilitation strategy to improve outcomes in this high-risk population. Rationale for Weight Loss Prior to Abdominal Wall Reconstruction Weight loss prior to AWR improves both technical and clinical outcomes (7). Reducing visceral and subcutaneous adiposity can facilitate fascial approximation, reduce tension at the repair site, and lower the risk of postoperative complications (8). Enhancing a patient's functional capacity before surgery can also contribute to optimal outcomes by improving cardiopulmonary function, glycemic control, and overall patient resilience, factors that collectively reduce surgical risk and improve the overall health of the patient (5,9). In our practices at University of Texas Health Austin and Endeavor Health, implementation of a ketogenic diet supplemented by daily aerobic exercise has been effective in optimizing patients for surgery and resulted in sustained improvements in health following surgery (10). While we do not have a specific cut point for body mass index (BMI) prior to open AWR, in general, we encourage weight loss in all overweight and obese patients as each unit of BMI is associated with a significant reduction in wound complications (3). In patients with large hernias, weight loss has the important impact of facilitating fascial closure by reducing hernia and intra-abdominal volume, and it also reduces tension on the closed wound. Previous studies demonstrate that lack of fascial closure increases recurrence rates by 7-fold and that increasing obesity directly correlates with elevated intra-abdominal pressure (11,12). Traditionally, these lifestyle modifications (e.g. ketogenic diet and daily aerobic exercise) have been the cornerstone of perioperative weight management, whereas surgical or endoscopic weight loss interventions were typically reserved for patients with more severe obesity or those without urgent indications for hernia repair. The purpose of this opinion piece is to advocate for the inclusion of ESG as a complementary strategy within the existing perioperative optimization paradigm. In particular, this may be a valuable emerging technology to achieve a longer-term effect in comparison to lifestyle modifications alone. Primary Endobariatric Therapies and Clinical Benefits Two principal endobariatric options for weight loss include intragastric balloon (IGB) therapy and endoscopic sleeve gastroplasty (ESG). IGB involves the endoscopic placement of a saline-filled or air-filled balloon in the stomach, which induces early satiety and reduces caloric intake. By far, the most commonly used ballon in the United States, the OrberaTM (Boston Scientific, El Coyol, Costa Rica) (13). IGB is Food and Drug Administration (FDA) approved for a maximum duration of six months. During this timeframe, it can induce an excess weight loss of 30-40% (14). However, this weight loss is typically not durable, and weight often recurs once the balloon is removed. Given these limitations, ESG is the preferred endoscopic intervention for patients requiring more sustained weight loss and metabolic improvement. That said, for carefully selected patients who required rapid, short term weight reduction without permanent anatomical changes, IGB still remains a viable option. Although longer-term follow-up is needed, ESG may be considered as an endobariatric approach in the AWR setting. ESG involves transoral placement of full thickness sutures to reduce the stomach's size by 70-80%, mimicking the restrictive anatomy of a surgical sleeve gastrectomy that limits food intake and induces changes in gastrointestinal hormones involved in satiety without the need for resection (15). Importantly, this technique avoids entering the peritoneal cavity, which is particularly advantageous in patients with prior abdominal surgeries or mesh implantation. ESG produces most of the weight loss within six months, which is beneficial for a patient who is being optimized for a hernia repair. In the multi-center ESG Randomized Interventional Trial (MERIT-Trial), investigators enrolled 209 participants with class 1 or class 2 obesity (BMI 30-40 kg/m2) to assess the effects of ESG combined with lifestyle modifications (15). After 52 weeks, the primary endpoint of 25% excess weight loss (EWL) was met in 77% of patients in the ESG group compared to only 12% in the control group (lifestyle modifications). Put differently, the mean percentage of total body weight loss at 52 weeks was 13.6% for the ESG group and 0.8% for the control group. Impressively, 68% of patients undergoing ESG maintained their weight loss at two...
- 21 August 2025
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 29 (12) , 102192
What to do when Heller myotomy fails: pneumatic dilation, redo Heller, or peroral endoscopic myotomy?
- 21 August 2025
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 29 (12) , 102192
What to do when Heller myotomy fails: pneumatic dilation, redo Heller, or peroral endoscopic myotomy?
- 21 July 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (9) , 6149-6154
Size and measurement technique both matter: accuracy of preoperative physical exam and computed tomography in predicting hernia size and current procedural terminology codes for incisional hernia
Background In 2023, new current procedural terminology (CPT) codes were introduced for anterior abdominal wall hernias based on hernia size, reducibility, and recurrence. When insurance prior authorization is required for hernia repair, it is necessary to estimate the size of the hernia to provide the appropriate CPT code. The aim of this study is to determine whether or not preoperative physical exam (PE) and imaging accurately predict the intraoperative size and thereby CPT code. Methods A prospectively maintained, single-institution hernia database was queried for patients undergoing elective incisional hernia repair from 2023 to 2024. Hernia size from most recent preoperative PE and CT scan within six months of surgery (if available) were compared to the intraoperative size. The percent congruence was determined between preoperative PE/CT and operative size/CPT code. Standard descriptive statistics were used. Results 145 patients underwent incisional hernia repair during the study period. One quarter (24.8%) of the hernias were recurrent and 11.7% were incarcerated. Preoperatively, 59.3% of patients had a CT scan available for review and 74.5% of patients had size documented on PE. Mean defect size was 5.5 × 5.3 cm by CT, 6.1 × 4.9 cm by PE, and 10 × 5.8 cm by intraoperative measurement (p < 0.01). In 46.9% of cases, the CPT code was different than that predicted on PE or CT; 97.2% of these discordant patients had hernias that are larger than predicted, and 43.4% had multiple smaller defects noted in the operative report. Conclusion Since the inception of the 2023 hernia CPT update, greater than four in ten patients had an operative CPT code that did not match the CPT code predicted on PE and CT. When CPT incongruence existed, hernia size intraoperatively was frequently larger than predicted and was associated with swiss cheese defects. A larger hernia CPT code may lead to increased out-of-pocket cost for patients who require preauthorization.
- 21 July 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (9) , 6149-6154
Size and measurement technique both matter: accuracy of preoperative physical exam and computed tomography in predicting hernia size and current procedural terminology codes for incisional hernia
Background In 2023, new current procedural terminology (CPT) codes were introduced for anterior abdominal wall hernias based on hernia size, reducibility, and recurrence. When insurance prior authorization is required for hernia repair, it is necessary to estimate the size of the hernia to provide the appropriate CPT code. The aim of this study is to determine whether or not preoperative physical exam (PE) and imaging accurately predict the intraoperative size and thereby CPT code. Methods A prospectively maintained, single-institution hernia database was queried for patients undergoing elective incisional hernia repair from 2023 to 2024. Hernia size from most recent preoperative PE and CT scan within six months of surgery (if available) were compared to the intraoperative size. The percent congruence was determined between preoperative PE/CT and operative size/CPT code. Standard descriptive statistics were used. Results 145 patients underwent incisional hernia repair during the study period. One quarter (24.8%) of the hernias were recurrent and 11.7% were incarcerated. Preoperatively, 59.3% of patients had a CT scan available for review and 74.5% of patients had size documented on PE. Mean defect size was 5.5 × 5.3 cm by CT, 6.1 × 4.9 cm by PE, and 10 × 5.8 cm by intraoperative measurement (p < 0.01). In 46.9% of cases, the CPT code was different than that predicted on PE or CT; 97.2% of these discordant patients had hernias that are larger than predicted, and 43.4% had multiple smaller defects noted in the operative report. Conclusion Since the inception of the 2023 hernia CPT update, greater than four in ten patients had an operative CPT code that did not match the CPT code predicted on PE and CT. When CPT incongruence existed, hernia size intraoperatively was frequently larger than predicted and was associated with swiss cheese defects. A larger hernia CPT code may lead to increased out-of-pocket cost for patients who require preauthorization.
- 16 July 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (9) , 6124-6131
Are outcomes of giant ventral hernia repair inferior? A propensity-matched analysis
Background Ventral hernia repair (VHR) of large defects poses significant technical challenges due to the size of the hernia and complexity of operative techniques required for fascial closure. This study examined clinical outcomes in “giant” open VHR (GVHR), with hernia defect size (HDS) ≥ 200 cm2, versus “non-giant” open VHR (NGVHR) with HDS < 200 cm2 using a propensity-matched approach. Methods A prospectively-maintained database from a tertiary hernia center was reviewed for patients undergoing open VHR. 1:1 propensity-score matching was performed for GVHR versus NGVHR based on age, BMI, comorbidities, fascial defect closure, primary vs recurrent repair, CDC wound class, and ASA score. A multivariable regression model evaluated whether wound complications increased odds of recurrence. CDC class III/IV wounds and concomitant intraabdominal procedures were excluded. Standard statistical analyses were performed. Results PSM yielded 254 well-matched pairs (all p > 0.05). Average age (59.7 ± 11.3 vs. 59.3 ± 12.3 years) and BMI (32.1 ± 6.5 vs. 32.4 ± 6.6 kg/m2) were similar between GVHR and NGVHR. Tobacco status was similar for current and former smokers (3.9% vs. 3.9%; 29.9% vs. 29.9%). GVHR had larger defect size (354.7 ± 132.1 vs. 103.8 ± 61.9 cm2; p < 0.001) and mesh size (1161.9 ± 450.0 vs. 771.2 ± 388.4 cm2; p < 0.001). In GVHR, Botulinum toxin injections (15.4% vs. 2.8%; p < 0.001) and component separation (50.6% vs. 23.7%; p < 0.001) were more frequent. Fascial defect was closed in 100% of both groups (p > 0.999). GVHR had higher rates of wound complications (33.5% vs. 15.4%; p < 0.001), respiratory insufficiency or failure (4.7% vs. 0.8%; p = 0.012), reoperation (9.8% vs. 4.7%; p = 0.028), and greater average length-of-stay (6.9 ± 5.1 vs. 5.0 ± 2.0 days; p < 0.001). There was no statistical difference in recurrence (4.3% vs. 2.4%; p = 0.217) or follow-up (24.0 ± 37.8 vs. 27.4 ± 40.4 months; p = 0.558). Conclusion GVHR often required chemical and mechanical component separation to achieve fascial closure. However, with large preperitoneal mesh overlap and fascial closure, outcomes of large defects in VHR are comparable to smaller defects.
- 16 July 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (9) , 6124-6131
Are outcomes of giant ventral hernia repair inferior? A propensity-matched analysis
Background Ventral hernia repair (VHR) of large defects poses significant technical challenges due to the size of the hernia and complexity of operative techniques required for fascial closure. This study examined clinical outcomes in “giant” open VHR (GVHR), with hernia defect size (HDS) ≥ 200 cm2, versus “non-giant” open VHR (NGVHR) with HDS < 200 cm2 using a propensity-matched approach. Methods A prospectively-maintained database from a tertiary hernia center was reviewed for patients undergoing open VHR. 1:1 propensity-score matching was performed for GVHR versus NGVHR based on age, BMI, comorbidities, fascial defect closure, primary vs recurrent repair, CDC wound class, and ASA score. A multivariable regression model evaluated whether wound complications increased odds of recurrence. CDC class III/IV wounds and concomitant intraabdominal procedures were excluded. Standard statistical analyses were performed. Results PSM yielded 254 well-matched pairs (all p > 0.05). Average age (59.7 ± 11.3 vs. 59.3 ± 12.3 years) and BMI (32.1 ± 6.5 vs. 32.4 ± 6.6 kg/m2) were similar between GVHR and NGVHR. Tobacco status was similar for current and former smokers (3.9% vs. 3.9%; 29.9% vs. 29.9%). GVHR had larger defect size (354.7 ± 132.1 vs. 103.8 ± 61.9 cm2; p < 0.001) and mesh size (1161.9 ± 450.0 vs. 771.2 ± 388.4 cm2; p < 0.001). In GVHR, Botulinum toxin injections (15.4% vs. 2.8%; p < 0.001) and component separation (50.6% vs. 23.7%; p < 0.001) were more frequent. Fascial defect was closed in 100% of both groups (p > 0.999). GVHR had higher rates of wound complications (33.5% vs. 15.4%; p < 0.001), respiratory insufficiency or failure (4.7% vs. 0.8%; p = 0.012), reoperation (9.8% vs. 4.7%; p = 0.028), and greater average length-of-stay (6.9 ± 5.1 vs. 5.0 ± 2.0 days; p < 0.001). There was no statistical difference in recurrence (4.3% vs. 2.4%; p = 0.217) or follow-up (24.0 ± 37.8 vs. 27.4 ± 40.4 months; p = 0.558). Conclusion GVHR often required chemical and mechanical component separation to achieve fascial closure. However, with large preperitoneal mesh overlap and fascial closure, outcomes of large defects in VHR are comparable to smaller defects.